Furthermore, Dub3-knockdown or WP1130 treatment significantly inhibited IL-6-mediated invasion of tumor cells (Figure 6D); however, WP1130 could not suppress IL-6-induced invasion in Dub3-knockdown cells. This evidence concerns the gene USP17L2 and neoplasm.